Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for exercise intolerance in long COVID with right ventricular preload dysfunction
RBR-7kyk2wyPhase 2Recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-COVID syndrome comparing Pyridostigmine with Placebo (2 arms). Started Nov 2023; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on RBR-7kyk2wy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7kyk2wy.